Skip to main content
SpringerLink
Log in
Palgrave Macmillan

Venture Capital and the European Biotechnology Industry

  • Book
  • © 2009

Overview

Authors:
  1. William Bains
    View author publications

    You can also search for this author in PubMed   Google Scholar

  • 2404 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Front Matter

    Pages i-viii
    Download chapter PDF

  2. Genes and Money in Europe: Why Did It Fail?

    • William Bains
    Pages 1-4

  3. The Biotechnology Industry and Venture Capital

    • William Bains
    Pages 5-22

  4. Europe Falls Behind

    • William Bains
    Pages 23-41

  5. Why Does Europe Do So Poorly? Some Inadequate Explanations

    • William Bains
    Pages 42-54

  6. Underinvestment in European Biotechnology

    • William Bains
    Pages 55-72

  7. Public Markets and Underinvestment

    • William Bains
    Pages 73-85

  8. VC Management of Companies

    • William Bains
    Pages 86-108

  9. VC Effects on Business Efficacy

    • William Bains
    Pages 109-122

  10. Investor Blockade of Business

    • William Bains
    Pages 123-139

  11. Pomp and Circumstance

    • William Bains
    Pages 140-149

  12. The Real VC Business Model

    • William Bains
    Pages 150-172

  13. What to Do about It: Government

    • William Bains
    Pages 173-188

  14. What to Do about It: Business

    • William Bains
    Pages 189-197

  15. Back Matter

    Pages 198-220
    Download chapter PDF
Back to top

Keywords

About this book

This book opens up the world on private equity investment in one of the hottest industries – Biotechnology. The book describes how Europe has fallen behind the US due to under-investment and bad management by the VCs who control the companies.  Detailed analysis shows why it is in VCs' interests to damage the very companies they invest in.

Reviews

'With this well-referenced book Dr Bains has filled an important lacuna within the literature on European biotech VC [venture capital] financing with an accessible primer for MBA students particularly those researching biopharma and VC business cases and for students undertaking specialist, industry-focused, post-graduate courses.' Gerhard Symons, Pharmaceutical Executive Europe

About the author

WILLIAM BAINS is an academic and entrepreneur with experience in research, company creation and venture capital. He has founded four biotechnology companies, helped found and finance another ten, and is internationally recognized both as
an innovator in biotechnology and a translator of innovation into business. He has written over 100 papers and teaches on innovation and entrepreneurship at Cambridge University, UK.

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation